Jefferies, which sees a 19% upside potential, says JB Chemicals is one of the fastest-growing domestic pharma company with a dominance in cardiac and gastro therapies
Jefferies, which sees a 19% upside potential, says JB Chemicals is one of the fastest-growing domestic pharma company with a dominance in cardiac and gastro therapies Jefferies, which sees a 19% upside potential, says JB Chemicals is one of the fastest-growing domestic pharma company with a dominance in cardiac and gastro therapies Moneycontrol Latest News Read More
